Breaking Out — The Real Story of Acne in 2026

Winlevi is a prescription cream that blocks oil-gland androgens on the skin. The FDA, Health Canada, the UK, Australia, and the EU have labelled it for acne in people 12 and older (the EU tighter on teen backs). Canada’s drug agency told public plans not to pay for it. Authorized is not funded.

Cabtreo is a once-daily prescription gel that puts clindamycin, adapalene, and benzoyl peroxide in one pump. The FDA and Health Canada have labelled it for acne in people 12 and older. Community pharmacy, not a trial slot. SAP is the wrong door in Canada. Europe, the UK, Australia, Japan, and Switzerland: marketing authorisation not found. Ontario LU 724 funds a year of it. Alberta only if the acne is scarring. Saskatchewan is full formulary. Nova Scotia is a regular benefit at 30 and under. Quebec's minister said inscrire. BC's live listing is unknown. Authorized is not the same listing everywhere.

Oral isotretinoin is the Accutane-class pill for severe acne that did not answer to first-line care. The FDA labels it for severe recalcitrant nodular acne in people 12 and older. Health Canada brands (Accutane, Epuris, Clarus, Absorica LD and others) also cover severe nodular/inflammatory acne, acne conglobata, and recalcitrant acne — still reserved for failure of conventional therapy. Pregnancy is an absolute contraindication. The US path runs through iPLEDGE REMS. Canada runs brand pregnancy-prevention programmes (PEER, CLEAR, C-A-R-E), not one national REMS. Authorized is not the same as funded.

If you cannot or will not take oral isotretinoin, a 1726 nm laser that targets oil glands is already a cleared clinic path in the United States and Canada for AviClear, with Accure also FDA-cleared in the US. Cash-pay in most places. The oral FASN pill denifanstat is not an enrolment door yet — China’s Phase 3 (NCT06192264) is COMPLETED; China’s NMPA accepted an NDA (watch only); Sagimet’s US AURORA Phase 3 has no RECRUITING NCT on ClinicalTrials.gov as of this draft.